Get the Weekly Intelligence Brief — top committee picks every Sunday.
NVO · NYSE · STOCK

Novo Nordisk A/S (NVO) Stock Analysis

Healthcare Updated August 23, 2026
$46.73
52W $35.12 – $64.16
48/100
$207.55B
11.5
0.35
AI Committee Verdict
Watch
48/100
Conviction: Contested · 40% agreement · 5 analysts
+2.2%
-3.6%
0.61:1
Contested

Is NVO Bullish or Bearish?

Mixed. Innellis AI committee rates Novo Nordisk A/S (NVO) Watch with a composite score of 48/100 , based on 5 analysts with 40% agreement. Last updated August 23, 2026.

What Would Change This View

Upgrade to Buy
Requires a committee score of 60.0 — +11.83 from today. Applies on the first day at or above the line; upgrades are never dampened.
Downgrade to Reduce
Requires the score to fall below 40.0 — -8.17 from today. The band boundary is 45.0, but a one-step downgrade must clear a further margin first. A score oscillating around the line should not change the rating every night.

Executive Summary

The committee is genuinely divided. Macro Analyst sees a compelling case. Growth Analyst remains cautious — growth rate is decelerating quarter over quarter -- the trend line matters more than the level. This disagreement is itself the signal — the setup is not clean in either direction.

Bull & Bear Case

Bull Case
Insufficient data for bull case.
Bear Case
  • Growth rate is decelerating quarter over quarter -- the trend line matters more than the level — Growth
  • MACD histogram negative -- bearish momentum — Technical
  • Bollinger bandwidth of 18.3% signals elevated volatility — Risk
Both cases are generated from quantitative data signals, not qualitative or forward-looking judgement. They summarise what the numbers say today.
Price History (6M)

AI Investment Committee

Committee Consensus As of August 23, 2026
Overall Committee Score
48/100
Agreement
40%
Analysts
5
Conviction
Contested
Sector Rank
Top 97%
of 192 Healthcare peers
Growth Analyst bearish
35 / 100 · Low confidence
Growth story is weak, decelerating, or inconsistent
− Growth rate is decelerating quarter over quarter -- the trend line matters more than the level
Technical Analyst neutral
48 / 100 · High confidence
Mixed or range-bound price action
− MACD histogram negative -- bearish momentum
Risk Analyst bearish
35 / 100 · Low confidence
Elevated risk from leverage, volatility, event exposure, or portfolio concentration -- size accordingly
− Bollinger bandwidth of 18.3% signals elevated volatility
Macro Analyst bullish
65 / 100 · Low confidence
Macro backdrop is supportive of risk assets generally, and this name's beta works in its favor
News Analyst neutral
58 / 100 · Low confidence
News flow is mixed or quiet -- no strong signal either way right now
Portfolio Manager neutral
45 / 100 · High confidence
Portfolio-level factors are mixed -- worth a deliberate sizing decision, not a default-size position
+ Portfolio position concentration is currently healthy
− Sector concentration is already high (HHI 3069.37)
Open Full Terminal →

Investment Thesis Evolution

Committee score moved marginally from 50.8 to 48.2.

Analyst-level changes:
  • Value Analyst abstained (was bullish at 62).

Comparing 2026-08-22 to 2026-08-23 (1 day apart).

Technical Analysis

RSI (14)
51.1
Neutral
MACD Histogram
-0.065
Bearish Momentum
Trend Direction
Sideways
Weekly: Downtrend
Market Structure
Hh Hl
Support
$45.06
Resistance
$47.75
Bollinger %B
0.45
Inside Bands
Price vs Moving Averages
EMA 9
$46.37 Above
EMA 21
$46.92 Below
EMA 50
$46.86 Below
EMA 200
$49.19 Below

Fundamental Analysis

Valuation
55
Growth
26
Profitability
100
Financial Health
50
Cash Flow
70
Valuation
P/E Ratio 11.5×
P/B Ratio 6.02×
PEG Ratio 2.29
Dividend Yield 2.49%
52W High $64.16
52W Low $35.12
Quality & Growth
ROE 5278.8%
ROA 1886.8%
Gross Margin 8064.8%
Operating Margin 4313.4%
Revenue Growth YoY
Debt / Equity 0.63
AI Fundamental Assessment
P/E ratio of 11.5 (inexpensive relative to a 15-40x range); Price-to-book of 6.0x; PEG ratio of 2.3 (under 1.0 suggests growth is undervalued relative to price); Return on equity of 52.8%; Return on assets of 18.9%; Net margin of 35.3%; Gross margin of 80.6%; Current ratio of 0.87 (tight short-term liquidity); Debt-to-equity of 0.63; Free cash flow per share is positive (11.05); Most recent quarter missed estimates by 5.6%; EPS growth decelerating (+9.8% -> -28.4% QoQ); Average YoY EPS growth of -20.3%; Analyst estimates falling over recent quarters
Get the Full NVO Analysis
Interactive charts · Live committee votes · Trade plan · Paper trading · AI Q&A
Open in Terminal →
Weekly Intelligence Brief
Get the committee's top-scored stocks every Sunday.
Free · No spam · Unsubscribe anytime